Phase 1/2a First-In-Human Study of BMS-986218 Monoclonal Antibody Alone and in Combination with Nivolumab in Advanced Solid Tumors

Sponsor
Bristol-Myers Squibb

Protocol Number
Bristol Myers Squibb CA022-001

To Learn More Call
201-510-0910